Fetzima 120 mg/1 (Levomilnacipran Hydrochloride CAPSULE, EXTENDED RELEASE) 120 mg/1

Fetzima 120 mg is an extended-release capsule containing levomilnacpran hydrochloride, used for managing depressive disorders. This medication is designed to provide sustained relief and is manufactured by Allergan, Inc.

Strength

120 mg/1

Pack Size

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2212-30)

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fetzima 120 mg is primarily used for the management of major depressive disorder (MDD). This medication works by affecting the balance of certain natural substances in the brain, which may help improve mood and emotional well-being. People often ask, 'What is Fetzima used for?' and the answer is that it is intended for those experiencing symptoms of depression.

Side Effects

Common effects of Fetzima 120 mg may include nausea, dry mouth, and increased sweating. Some users also report constipation, decreased appetite, and insomnia. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

Fetzima 120 mg should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Fetzima 120 mg may interact with other medications, including those that affect serotonin levels, such as SSRIs and SNRIs. It is also important to be cautious when consuming alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare professional before starting any new medication.

Frequently Asked Questions

Fetzima is used for the management of major depressive disorder (MDD). It helps improve mood and emotional well-being by affecting certain natural substances in the brain.

Fetzima 120 mg should be taken orally, usually once daily, with or without food. Follow the instructions provided by your healthcare professional.

Common side effects may include nausea, dry mouth, increased sweating, constipation, decreased appetite, and insomnia. These effects can vary and may subside over time.

It is advisable to avoid alcohol while taking Fetzima, as it can increase the risk of side effects. Always consult your healthcare provider for personalized advice.

Store Fetzima at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.